Literature DB >> 11738747

One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination.

D L Lodmell1, M J Parnell, J R Bailey, L C Ewalt, C A Hanlon.   

Abstract

We have previously shown that Macaca fascicularis (Cynomologus) monkeys receiving a primary and either one or two booster rabies DNA vaccinations are protected against rabies virus. In this study, we determined whether monkeys that had been vaccinated only once via gene gun or intramuscularly (i.m.) with different concentrations of DNA would be protected against rabies virus challenge. Neutralizing antibody responses were assayed for 1 year before the monkeys were challenged. Neutralizing antibody was detected at least 50 days earlier in gene gun vaccinated as compared to i.m. vaccinated animals. Prior to viral challenge, all (6/6, 100%) gene gun vaccinated animals, but only 3/6 (50%) i.m. vaccinated animals seroconverted. In general, antibody titers of the gene gun vaccinated animals were higher than the titers of the i.m. vaccinated animals. There was no correlation between the concentration of DNA used for vaccination, the neutralizing antibody responses elicited and protection against viral challenge. Seven days after viral challenge, a rapid and strong anamnestic antibody response was elicited in 100% of the gene gun vaccinated monkeys and in four i.m. vaccinated monkeys. Neutralizing antibody remained undetectable in two i.m. vaccinated monkeys. Overall, 60% (3/5) of the gene gun vaccinated animals and 87% (5/6) of the i.m. vaccinated monkeys survived viral challenge. This study is the first, to our knowledge, to show long-term protection of non-human primates against a human viral pathogen using a DNA vaccination protocol that did not include a booster immunization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738747     DOI: 10.1016/s0264-410x(01)00392-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.

Authors:  Jonathan Cenna; Gene S Tan; Amy B Papaneri; Bernhard Dietzschold; Matthias J Schnell; James P McGettigan
Journal:  Vaccine       Date:  2008-09-18       Impact factor: 3.641

Review 2.  The cell biology of rabies virus: using stealth to reach the brain.

Authors:  Matthias J Schnell; James P McGettigan; Christoph Wirblich; Amy Papaneri
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

3.  Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates.

Authors:  Jonathan Cenna; Meredith Hunter; Gene S Tan; Amy B Papaneri; Erin P Ribka; Matthias J Schnell; Preston A Marx; James P McGettigan
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

Review 4.  New human rabies vaccines in the pipeline.

Authors:  Anthony R Fooks; Ashley C Banyard; Hildegund C J Ertl
Journal:  Vaccine       Date:  2018-08-25       Impact factor: 3.641

Review 5.  Lyssaviruses: current trends.

Authors:  Susan A Nadin-Davis; Christine Fehlner-Gardiner
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

6.  Evaluation of Vaccination Strategy Against Rabies in Hong Kong Macaques.

Authors:  Paolo Martelli; Sophie St-Hilaire; Wai-Suk Hui; Karthiyani Krishnasamy; Ioannis Magouras; Omid Nekouei
Journal:  Front Vet Sci       Date:  2022-03-21

7.  Novel vaccines to human rabies.

Authors:  Hildegund C J Ertl
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29

8.  The present and future of rabies vaccine in animals.

Authors:  Dong-Kun Yang; Ha-Hyun Kim; Kyung-Woo Lee; Jae-Young Song
Journal:  Clin Exp Vaccine Res       Date:  2013-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.